ALT, AST, GGT, TG, and FPG were increased in 16% (4/25), 24% (6/25), 16% (4/25), 32% (8/25), and 44% (11/25) of fatty liver group and in 8% (2/25), 28% (7/25), 32% (8/25), 20% (5/25), and 12% (3/25) of nonfatty liver group; respectively. This evidence concerns the gene GPT and fatty liver disease.